• Mashup Score: 0

    In this week’s infectious disease news, the Novavax COVID-19 booster gets authorized in the US; Moderna reports topline data on its influenza-COVID-19 combination vaccine; the differences between live biotherapeutic products and conventional FMTs; and the influence of alcohol on hepatitis C treatment.

    Tweet Tweets with this article
    • This week: #Novavax #COVID19 booster gets FDA authorization; #Moderna reports data on its influenza-COVID-19 combination vaccine; the differences between live biotherapeutic products and conventional FMTs; and the influence of alcohol on HCV Treatment. https://t.co/yDzM6RARtL https://t.co/YE4OUa6FwT

  • Mashup Score: 4

    An ID specialist looks in to the new COVID vaccines Novavax and Covaxin and how they may help with vaccine hesitancy.

    Tweet Tweets with this article
    • Have discussed mRNA and DNA-adenovirus vaccines before. Here is a piece on #Novavax & #Covaxin (https://t.co/J0JT47Obku) and here is a thread on #nasalvaccines https://t.co/h4fYHkzqDM

  • Mashup Score: 70

    An ID specialist looks in to the new COVID vaccines Novavax and Covaxin and how they may help with vaccine hesitancy.

    Tweet Tweets with this article
    • yay @US_FDA on Novavax as a booster! Would be good to get #Covaxin too sometime as booster. I write about #Novavax and #Covaxin in this primer for @medscape: https://t.co/J0JT485emu https://t.co/M0O9YHs6qs